Read on Twitter
Did you know that pregnant people with #antiphospholipidsyndrome (APS) have an increased risk of adverse maternal & fetal outcomes? (1/4)
APS is characterized by #thrombosis and/or obstetric morbidity in the presence of #antiphospholipid antibodies. For pregnant people, this means increased likelihood of severe #preeclampsia, preterm birth, & #neonatalmortality. (2/4) 
Studies show that complement activity plays a key role in aPL-mediated #thrombosis & obstetric complications. And fortunately, complement inhibitors, like #eculizumab, offer promise of improved outcomes for pregnant people living with APS. (3/4)
Access ASH resources and learn more about #classicalheme conditions affecting pregnant people as well as the critical connection between #maternalhealth & #hematology 🩸: loom.ly/v-7kxSs (4/4)
• • •
Missing some Tweet in this thread? You can try to
force a refresh
